Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BEAT-SHOCK (Basel Evaluation of Acute Therapy in Cardiogenic SHOCK) Registry

NCT07643610 is registered in ClinicalTrials.gov with University Hospital, Basel, Switzerland as lead sponsor.

NCT NCT07643610
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07643610 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BEAT-SHOCK (Basel Evaluation of Acute Therapy in Cardiogenic SHOCK) Registry
Lead sponsor
University Hospital, Basel, Switzerland
Phase
Observational
Overall status
Recruiting
Start date
October 1, 2025
Completion date
October 1, 2035
Enrollment
8,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute decompensated heart failure, cardiogenic shock, fulminant myocarditis, myocardial infarction (mi), perioperative cardiogenic shock, post-cardiotomy, severe valvular disease